Menu Search
Equities

Wai Yuen Tong Medicine Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
897:HKG.HZ

Wai Yuen Tong Medicine Holdings Ltd

Actions
  • Price (HKD)0.37
  • Today's Change0.025 / 7.25%
  • Shares traded393.76k
  • 1 Year change+21.31%
  • Beta0.1107
Data delayed at least 15 minutes, as of Feb 06 2026 07:02 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Wai Yuen Tong Medicine Holdings Ltd is an investment holding company principally engaged in the production and sales of pharmaceutical products. The Company operates through three segments. The Production and Sale of Chinese Pharmaceutical and Health Food Products segment is mainly engaged in the manufacture, processing and sale of traditional Chinese medicine in China and Hong Kong. This segment also provides Chinese medicines under the brand Wai Yuen Tong and products manufactured with traditional prescriptions, as well as traditional Chinese medicine services and management and promotion services. The Production and Sale of Western Pharmaceutical and Health Food Products segment is engaged in the processing and sales of Western pharmaceutical products and personal care products under the brands Madame Pearl’s and Pearl’s. The Property Investment segment is engaged in investment in commercial properties for rental income.

  • Revenue in HKD (TTM)721.27m
  • Net income in HKD-13.83m
  • Incorporated1994
  • Employees726.00
  • Location
    Wai Yuen Tong Medicine Holdings Ltd5th Floor, Wai Yuen Tong Medicine Bldng9 Wang Kwong RoadKowloon Bay, Kowloon Hong KongHKG
  • Phone+852 23128202
  • Fax+852 35266630
  • Websitehttps://www.wyth.net/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.